BIOMAT Database Logo BIOMAT Database Logo

The inhibitory activity of a peptide derivative against the growth of simian immunodeficiency virus in C8166 cells. 1991

J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
Research Centre, Roche Products Ltd., Welwyn Garden City, Herts, UK.

The peptide derivative Ro 31-8959 is a potent and selective inhibitor of the aspartic proteinases encoded by HIV-1 and HIV-2 and it arrests the growth of both viruses in cell culture. We have demonstrated similar effects against the simian immunodeficiency virus SIVmac251 in the human T-cell line, C8166 (ED50 = 6nM) with a therapeutic index of 4,500. The antiviral activity of Ro 31-8959 was 250 and 22 times greater than that of ddI and ddC, respectively. The mode of action was confirmed by accumulation of the polyprotein p55 with concomitant reduction of the cleavage product, p27, and by the production of immature virions.

UI MeSH Term Description Entries
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D016047 Zalcitabine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. 2',3'-Dideoxycytidine,Dideoxycytidine,ddC (Antiviral),HIVID Roche,Hivid,NSC-606170,2',3' Dideoxycytidine,NSC 606170,NSC606170
D016049 Didanosine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. 2',3'-Dideoxyinosine,Dideoxyinosine,ddI (Antiviral),NSC-612049,Videx,2',3' Dideoxyinosine,NSC 612049,NSC612049
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV

Related Publications

J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
A new fluoroquinolone derivative exhibits inhibitory activity against human immunodeficiency virus type 1 replication.
January 1999, Chemotherapy,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
Growth inhibitory activity of synthetic mannan derivative against tumor cells in vitro.
January 1978, Chemical & pharmaceutical bulletin,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
A Block to Efficient Replication of Simian Immunodeficiency Virus in C8166 Cells Can Be Overcome by Duplication of the NF-kappaB Binding Site.
January 1996, Journal of biomedical science,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
[Electron microscopic investigation of CD4+ lymphocyte cell line C8166 after infection with simian immunodeficiency virus (SIV)].
April 2003, DTW. Deutsche tierarztliche Wochenschrift,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
Pyrimidone derivative inhibits simian immunodeficiency virus-induced apoptosis of CEM x174 cells.
February 2009, Cell biology international,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus.
December 2021, Emerging microbes & infections,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
January 2017, Journal of virology,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
Vaccine protection against simian immunodeficiency virus infection.
August 1989, Proceedings of the National Academy of Sciences of the United States of America,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
Mechanisms of protection against simian immunodeficiency virus infection.
May 2002, Vaccine,
J A Martin, and M A Mobberley, and S Redshaw, and A Burke, and A S Tyms, and T A Ryder
Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
May 1995, Lancet (London, England),
Copied contents to your clipboard!